Join our team as Head of Research and Access (Maternity Cover)

Drive forward our common fight for access to healthcare and spearhead the global collaboration between the MSIF movement’s MS organisations, advancing the search for scientific understanding and MS treatments.

Cykelnerven 2019

Each year, seasoned riders from around the world take on over 400km of the toughest climbs from the Tour De France just weeks before the official race. It's the ride that every cyclist dreams of, but only the toughest can complete.

New map changes understanding of immune cells in the brain

A new international study has mapped a type of immune cell, the microglia, in the human and mouse brain for the first time. Microglia are thought to play a role in the progression of MS. This research has changed the understanding of how these cells function, and has important implications for MS.

Early intensive treatment gives better outcomes

New study shows that early use of high efficacy treatment for MS improves long term disability outcomes, rather than starting on a moderately effective therapy and escalating to a stronger medication.

Food allergies may be linked to more MS relapses

In a recent study, scientists have shown that people with MS who have food allergies are more likely to experience clinical attacks and lesions in the brain than those without allergies or with other allergies that are unrelated to food.

The next Atlas of MS is underway

MSIF’s Atlas of MS with new data on the number of people living with MS across the world, and the challenges they face.

Our progress – together we’re stronger than MS

Driving global change - progress made by the global MSIF movement

Screening environmental chemicals that may influence MS

976 chemicals were screened to assess their impact on MS.

Stem cell trial results published

A trial has compared a cancer chemotherapy to MS treatments, but further research is needed to understand how effective the treatment is in comparison to other MS treatments.

Advances in research increase rate of MS treatment changes

Studies show that improved MS medications and advances in MRI technology have led to an increased rate of doctors changing courses of MS treatment and a reduced tolerance of any sign of disease activity, with doctors more readily switching treatments in cases of low disease activity.